HAIR CARE DESK · UNITED STATESPRACTICAL CALLEDITORIAL CHECK · 2026-08-26
STRAND REPORT

Claims, context, and what the bottle leaves out.

DECISION DESK

Read hair-density and growth-serum claims without confusing breakage and loss

Determine whether a product makes a cosmetic appearance claim or crosses into hair-growth and hair-loss treatment territory.

5 SOURCE REFERENCESOWNED USE TEST NOT EXECUTEDU.S. ROUTINE CONTEXT

THE DESK'S CALL

The headline.

Our call: reject vague growth claims
02

ON THE RECORD

What keeps the headline honest.

This is an editorial conclusion from the stated context. It is not a claimed product trial, diagnosis, or universal ranking.

Decision change

Requires claim wording, endpoint, duration, and product status before discussing efficacy.

Evidence boundary

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

03

What could overturn the headline.

THE COUNTER-CASE

  • Reduced breakage can look like improved density without changing growth.
  • New or persistent hair loss should not be delayed by cosmetic serum trials.

STILL UNREPORTED

  • The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.
04

BUSINESS DESK

Commercial disclosure

This report contains no affiliate link or paid product placement. We do not turn manufacturer statements into owned findings, and we do not imply a product was used when no dated hands-on protocol exists.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Our call: reject vague growth claims

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

Reduced breakage can look like improved density without changing growth.

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. Health Products Compliance GuidanceU.S. Federal Trade Commission
Data and test conditions still required
Product function and category

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Ingredient list for the current version

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Amount, contact time, and frequency

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Evidence for the specific claim

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Standardized photography conditions

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Regulatory status and applicable labeling

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Separate scalp-care choices from symptoms

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Trace a general claim to its evidence

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Classify status by intended use and claim

Define and retain the conditions, date, material, and outcome before presenting any owned observation.